| A serological assay to detect SARS-CoV-2 seroconversion in humans F Amanat, D Stadlbauer, S Strohmeier, THO Nguyen, V Chromikova, ... Nature medicine 26 (7), 1033-1036, 2020 | 2029 | 2020 |
| SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling L Miorin, T Kehrer, MT Sanchez-Aparicio, K Zhang, P Cohen, RS Patel, ... Proceedings of the National Academy of Sciences 117 (45), 28344-28354, 2020 | 485 | 2020 |
| Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer T Aydillo, AS Gonzalez-Reiche, S Aslam, A van de Guchte, Z Khan, ... New England journal of medicine 383 (26), 2586-2588, 2020 | 448 | 2020 |
| A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial R Nachbagauer, J Feser, A Naficy, DI Bernstein, J Guptill, EB Walter, ... Nature medicine 27 (1), 106-114, 2021 | 254 | 2021 |
| Immunological imprinting of the antibody response in COVID-19 patients T Aydillo, A Rombauts, D Stadlbauer, S Aslam, G Abelenda-Alonso, ... Nature communications 12 (1), 3781, 2021 | 190 | 2021 |
| A 5-year prospective multicenter evaluation of influenza infection in transplant recipients D Kumar, VH Ferreira, E Blumberg, F Silveira, E Cordero, ... Clinical Infectious Diseases 67 (9), 1322-1329, 2018 | 174 | 2018 |
| Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission A Escalera, AS Gonzalez-Reiche, S Aslam, I Mena, M Laporte, RL Pearl, ... Cell host & microbe 30 (3), 373-387. e7, 2022 | 153 | 2022 |
| Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms AE Livanos, D Jha, F Cossarini, AS Gonzalez-Reiche, M Tokuyama, ... Gastroenterology 160 (7), 2435-2450. e34, 2021 | 148 | 2021 |
| MHC class II proteins mediate cross-species entry of bat influenza viruses U Karakus, T Thamamongood, K Ciminski, W Ran, SC Günther, MO Pohl, ... Nature 567 (7746), 109-112, 2019 | 125 | 2019 |
| Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1–2, a randomized controlled clinical trial E Cordero, C Roca-Oporto, A Bulnes-Ramos, T Aydillo, J Gavaldà, ... Clinical Infectious Diseases 64 (7), 829-838, 2017 | 104 | 2017 |
| Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave A Gutiérrez-Pizarraya, P Pérez-Romero, R Alvarez, TA Aydillo, ... Journal of Infection 65 (5), 423-430, 2012 | 101 | 2012 |
| TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation JSY Ho, BWY Mok, L Campisi, T Jordan, S Yildiz, S Parameswaran, ... Cell 184 (10), 2618-2632. e17, 2021 | 85 | 2021 |
| Therapy with m-TOR inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients E Cordero, A Perez-Ordonez, TA Aydillo, J Torre-Cisneros, J Gavalda, ... American Journal of Transplantation 11 (10), 2205-2213, 2011 | 55 | 2011 |
| Synthetically derived bat influenza A-like viruses reveal a cell type-but not species-specific tropism ÉA Moreira, S Locher, L Kolesnikova, H Bolte, T Aydillo, A García-Sastre, ... Proceedings of the National Academy of Sciences 113 (45), 12797-12802, 2016 | 54 | 2016 |
| Autoantibodies against type I IFNs in patients with critical influenza pneumonia Q Zhang, A Pizzorno, L Miorin, P Bastard, A Gervais, T Le Voyer, L Bizien, ... Journal of Experimental Medicine 219 (11), e20220514, 2022 | 52 | 2022 |
| Limited extent and consequences of pancreatic SARS-CoV-2 infection V van der Heide, S Jangra, P Cohen, R Rathnasinghe, S Aslam, T Aydillo, ... Cell Reports 38 (11), 2022 | 52 | 2022 |
| Gastrointestinal involvement attenuates COVID-19 severity and mortality AE Livanos, D Jha, F Cossarini, AS Gonzalez-Reiche, M Tokuyama, ... MedRxiv, 2020.09. 07.20187666, 2020 | 40 | 2020 |
| Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression SM El Jamal, E Pujadas, I Ramos, C Bryce, ZM Grimes, F Amanat, ... Human Pathology 114, 110-119, 2021 | 38 | 2021 |
| Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe P Perez-Romero, A Bulnes-Ramos, J Torre-Cisneros, J Gavaldá, ... Clinical Microbiology and Infection 21 (11), 1040. e11-1040. e18, 2015 | 38 | 2015 |
| Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study D Viasus, C Marinescu, A Villoslada, E Cordero, J Gálvez-Acebal, ... Journal of Infection 67 (3), 185-193, 2013 | 37 | 2013 |
